跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
泽普思 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Flurbiprofen Cataplasms
Approved
化学药品
Flurbiprofen Cataplasms
MIKASA SEIYAKU CO., LTD.
🇨🇳 National Medical Products Administration
Approval Date
Oct 30, 2019
Approval ID
7MazXbFdcPH
Company
MIKASA SEIYAKU CO., LTD.
Type
化学药品
Approval Details
Approval Id
7MazXbFdcPH
Approval Number
H20160288
Generic Name
氟比洛芬凝胶贴膏
Generic Name En
Flurbiprofen Cataplasms
Brand Name
泽普思
Drug Type
化学药品
Dosage Form
贴膏剂
Strength
40mg/贴
Reg Date
2019-10-30
Expired Date
2024-10-29
Company Name
MIKASA SEIYAKU CO., LTD.
Company Address
2-3-1,TOYOTAMA-KITA,NERIMA-KU,TOKYO,JAPAN
Production Company Name
mikasa seiyaku co.,ltd kakegawa factory
Production Company Address
2679 KUNIYASU,KAKEGAWA CITY,SHIZUOKA PREFECTURE,JAPAN
Company Detail Path
/organization/mikasa-seiyaku-co-ltd
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Oct 30, 2019
Approval ID
7MazXbFdcPH
Type
化学药品
Back to NMPA Approvals